SIRT3: A New Regulator of Cardiovascular Diseases
Wei Sun, Caixia Liu, Qiuhui Chen et al. · Oxidative Medicine and Cellular Longevity · 2018 · Review
Full textCC BY
Geriatrics and Gerontology
Filters2 filters applied
Status
- Expression of concern
- Corrected
- No notice
- From publisher notices and Retraction Watch. Not checked means nobody has looked yet.
Year
Readable here
Study type
Identifying older adults at risk of harm following elective surgery: a systematic review and meta-analysis
Jennifer Watt, Andrea C. Tricco, Catherine Talbot-Hamon et al. · BMC Medicine · 2018 · Meta-analysis
Full textCC BY
Home-based preoperative rehabilitation (prehab) to improve physical function and reduce hospital length of stay for frail patients undergoing coronary artery bypass graft and valve surgery
Iain Waite, Ranjit Deshpande, Max Baghai et al. · Journal of Cardiothoracic Surgery · 2017
Full textCC BY
The Role of Resveratrol in Cancer Therapy
Jeong-Hyeon Ko, Gautam Sethi, Jae-Young Um et al. · International Journal of Molecular Sciences · 2017 · Review
Full textCC BY
Influence of Poor Oral Health on Physical Frailty: A Population‐Based Cohort Study of Older British Men
Sheena E. Ramsay, Efstathios Papachristou, Richard G. Watt et al. · Journal of the American Geriatrics Society · 2017
Full textCC BY
A frailty index from common clinical and laboratory tests predicts increased risk of death across the life course
Joanna M. Blodgett, Olga Theou, Susan E. Howlett et al. · GeroScience · 2017
Full textCC BY
Expression of concern SIRT1 Activation by Resveratrol Alleviates Cardiac Dysfunction via Mitochondrial Regulation in Diabetic Cardiomyopathy Mice
Sai Ma, Jing Feng, Ran Zhang et al. · Oxidative Medicine and Cellular Longevity · 2017
Full textCC BY
Prevalence of frailty in Japan: A systematic review and meta-analysis
Gotaro Kojima, Steve Iliffe, Yu Taniguchi et al. · Journal of Epidemiology · 2017 · Meta-analysis
Full textCC BY
An open-label, non-randomized study of the pharmacokinetics of the nutritional supplement nicotinamide riboside (NR) and its effects on blood NAD+ levels in healthy volunteers
Sophia E. Airhart, Laura M. Shireman, Linda J. Risler et al. · PLOS ONE · 2017
Full textCC BY
SIRT6 safeguards human mesenchymal stem cells from oxidative stress by coactivating NRF2
Huize Pan, Di Guan, Xiaomeng Liu et al. · Cell Research · 2016
Full textCC BY
Nicotinamide Riboside Opposes Type 2 Diabetes and Neuropathy in Mice
Samuel A.J. Trammell, Benjamin J. Weidemann, Ankita Chadda et al. · Scientific Reports · 2016
Full textCC BY
Associations of frailty with health care costs – results of the ESTHER cohort study
Jens-Oliver Bock, Hans-Helmut König, Hermann Brenner et al. · BMC Health Services Research · 2016
Full textCC BY
Sirtuins in glucose and lipid metabolism
Xin Ye, Meiting Li, Tianyun Hou et al. · Oncotarget · 2016 · Review
Full textCC BY
The protective role of Sirt1 in vascular tissue: its relationship to vascular aging and atherosclerosis
Munehiro Kitada, Yoshio Ogura, Daisuke Koya · Aging · 2016 · Review
Full textCC BY
NRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells
Joanna Ratajczak, Magali Joffraud, Samuel A. J. Trammell et al. · Nature Communications · 2016
Full textCC BY
Resveratrol and Cardiovascular Diseases
Dominique Bonnefont-Rousselot · Nutrients · 2016 · Review
Full textCC BY
Selective Sirt2 inhibition by ligand-induced rearrangement of the active site
Tobias Rumpf, Matthias Schiedel, Berin Karaman et al. · Nature Communications · 2015
Full textCC BY
Corrected Association between new indices in the locomotive syndrome risk test and decline in mobility: third survey of the ROAD study
Noriko Yoshimura, Shigeyuki Muraki, Hiroyuki Oka et al. · Journal of Orthopaedic Science · 2015
Full textCC BY
Sirtuin Functions in Female Fertility: Possible Role in Oxidative Stress and Aging
Carla Tatone, Giovanna Di Emidio, Maurizio Vitti et al. · Oxidative Medicine and Cellular Longevity · 2015 · Review
Full textCC BY
No evidence that frailty modifies the positive impact of antihypertensive treatment in very elderly people: an investigation of the impact of frailty upon treatment effect in the HYpertension in the Very Elderly Trial (HYVET) study, a double-blind, placebo-controlled study of antihypertensives in people with hypertension aged 80 and over
Jane Warwick, Emanuela Falaschetti, Kenneth Rockwood et al. · BMC Medicine · 2015 · Randomised trial
Full textCC BY